Page last updated: 2024-08-21

aminoimidazole carboxamide and Prediabetic State

aminoimidazole carboxamide has been researched along with Prediabetic State in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fleming, TH; Groener, JB; Kopf, S; Mendler, M; Nawroth, PP; Okun, JG; Riedinger, C1
Lee, Y; Li, J; McCorkle, S; Ruderman, NB; Saha, AK; Unger, RH; Wang, M; Yu, X1

Trials

1 trial(s) available for aminoimidazole carboxamide and Prediabetic State

ArticleYear
Urine levels of 5-aminoimidazole-4-carboxamide riboside (AICAR) in patients with type 2 diabetes.
    Acta diabetologica, 2018, Volume: 55, Issue:6

    Topics: Adenylate Kinase; Adult; Aged; Aminoimidazole Carboxamide; Animals; Case-Control Studies; Cohort Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prediabetic State; Ribonucleotides; Risk Factors; Risk Reduction Behavior; Signal Transduction

2018

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Prediabetic State

ArticleYear
Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.
    Diabetologia, 2004, Volume: 47, Issue:11

    Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Animals; Diabetes Mellitus; Diglycerides; Enzyme Activation; Homozygote; Leptin; Lipid Metabolism; Male; Malonyl Coenzyme A; Mice; Mice, Obese; Prediabetic State; Rats; Rats, Mutant Strains; Rats, Zucker; Ribonucleotides

2004